References
- Arenas R, Dominguez CJ, Fernandez LM, Open randomized comparison of itraconazole versus terbina- fine in onychomycosis. Int J Dermatol (1995) 34: 138–43.
- Brandrup F, Larsen PO, Long-term follow-up of toenail onychomycosis treated with terbinafine (letter). Acta Derm Venereol (1997) 77: 238.
- Brautigam M, Nolting S, Schopf RE et al, Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group. BMJ (1995) 311: 919–22.
- Brautigam M, Nolting S, Schopf RE et al, German randomised double-blind multicentre comparison of terbinafine and itraconazole for the treatment of toenail tinea infection. Br J Dermatol (1996) 134 (suppl 46): 18–21.
- Brautigam M, Weidinger G, Nolting S, Successful treatment of toenail mycosis with terbinafine and itraconazole gives long term benefits. BMJ (1998) 317: 1084.
- Brautigam M, Terbinafine versus itraconazole: a con- trolled clinical comparison in onychomycosis of the toenails. J Am Acad Dermatol (1998) 38: S53–S56.
- De Cuyper C, Long-term evaluation of terbinafine 250 and 500 mg daily in a 16-week oral treatment for toenail onychomycosis. Br J Dermatol (1996) 135: 156–7.
- Evans EG, Sigurgeirsson B, Double blind, randomised study of continuous terbinafine compared with inter- mittent itraconazole in treatment of toenail onychomy- cosis. The LION Study Group. BMJ (1999) 318: 1031–5.
- Heikkila H, Stubb S, Long-term results of patients with onychomycosis treated with itraconazole. Acta Derm Venereol (1997) 77: 70–1.
- Hofmann H, Brautigam M, Weidinger G et al, Treatment of toenail onychomycosis. A randomised, double-blind study with terbinafine and griseofulvin. LAGOS II Study Group. Arch Dermatol (1995) 131: 919–22.
- Kejda J, Itraconazole pulse therapy vs. continuous terbinafine dosing for toenail onychomycosis. Postgrad Med (1999) Spec No: 12–5.
- Piepponen T, Blomqvist K, Brandt H et al, Efficacy and safety of itraconazole in the long-term treatment of onychomycosis. J Antimicrob Chemother (1992) 29: 195–205.
- Sigurgeirsson B, Billstein S, Rantanen T et al, LION Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. itraco- nazole, in Onychomycosis. Br J Dermatol (1999) 141 (suppl 56): 5–14.
- Tausch I, Brautigam M, Weidinger G et al, Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study Group. Br J Dermatol (1997) 136: 737–42.
- Torok I, Simon G, Dobozy A et al, Long-term post- treatment follow-up of onychomycosis treated with terbinafine: a multicentre trial. Mycoses (1998) 41: 63–5.
- Tosti A, Piraccini BM, Stinchi C et al, Treatment of dermatophyte nail infections: an open randomised study comparing intermittent terbinafine therapy with con- tinuous terbinafine treatment and intermittent itraco- nazole therapy. J Am Acad Dermatol (1996) 34: 595–600.
- Tosti A, Piraccini BM, Stinchi C et al, Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up. Dermatology (1998) 197: 162–6.
- Watson AB, Marley JE, Ellis DH et al, Long-term follow- up of patients with toenail onychomycosis after treat- ment with terbinafine. Australas J Dermatol (1998) 39: 29–30.